# Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause

> **NCT00256685** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 568 (—)

## Conditions studied

- Menopause
- Hot Flashes
- Sleep Disorders

## Interventions

- **DRUG:** DVS-233 SR

## Key facts

- **NCT ID:** NCT00256685
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 568 (—)
- **Last updated:** 2006-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256685, "Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00256685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*